Home › Funds › Column Group LLC › ORIC
Column Group LLC position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
Column Group LLC reported holding 3,540,777 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$38.3M, representing 43.53% of its reported portfolio and ranking #2 among its reported holdings. Column Group LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Column Group LLC's ORIC position evolved
Column Group LLC first disclosed a stake in ORIC in Q3 2023 at 3,568,181 shares (US$21.6M). The position peaked in Q1 2024 at 3,540,777 shares, worth US$48.7M. Across 12 filings, Column Group LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 3,540,777 shares valued at US$38.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.57M | $21.59M | New |
| Q4 2023 | 3.57M | $32.83M | Hold |
| Q1 2024 | 3.54M | $48.69M | Reduce |
| Q2 2024 | 3.54M | $25.03M | Hold |
| Q3 2024 | 3.54M | $36.29M | Hold |
| Q4 2024 | 3.54M | $28.57M | Hold |
| Q1 2025 | 3.54M | $19.76M | Hold |
| Q2 2025 | 3.54M | $35.94M | Hold |
| Q3 2025 | 3.54M | $42.49M | Hold |
| Q4 2025 | 3.54M | $28.96M | Hold |
| Q1 2026 | 3.54M | $44.86M | Hold |
| Q2 2026 | 3.54M | $38.35M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- EcoR1 Capital, LLC 6.73M sh · $72.87M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Siren, L.L.C. 3.00M sh · $32.47M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Vivo Capital, LLC 1.85M sh · $20.02M · Q2 2026
- Defilade Capital Management, L.P. 1.05M sh · $11.35M · Q2 2026
More on Column Group LLC
FAQ
How long has Column Group LLC held ORIC?
Column Group LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Column Group LLC's current position in ORIC?
As of Q2 2026, Column Group LLC holds 3.54M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $38.35M, representing 43.53% of its reported portfolio and ranking #2.
Has Column Group LLC been buying or selling ORIC?
In the latest 13F filing (Q2 2026), Column Group LLC held unchanged its position in ORIC. The position peaked in Q1 2024 at 3.54M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.